Viewing Study NCT00992134


Ignite Creation Date: 2025-12-25 @ 2:18 AM
Ignite Modification Date: 2026-02-11 @ 10:29 PM
Study NCT ID: NCT00992134
Status: COMPLETED
Last Update Posted: 2012-09-26
First Post: 2009-10-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Immunochemotherapy With Rituximab-Bendamustine-Cytarabine (R-BAC) for Patients With Mantle Cell Lymphoma
Sponsor: St. Bortolo Hospital
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Lymphoma, Mantle-Cell View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Lymphoma, Mantle-Cell View
None Bendamustine View
None Cytarabine View
None Rituximab View
None Treatment View
None Combination chemotherapy View